TD ASSET MANAGEMENT INC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 92 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.28 and the average weighting 1.3%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$1,684,000
+19.2%
100,776
+2.9%
0.00%0.0%
Q1 2020$1,413,000
-61.6%
97,976
-11.0%
0.00%
-60.0%
Q4 2019$3,684,000
+71.8%
110,076
+7.5%
0.01%
+66.7%
Q3 2019$2,144,000
+2.9%
102,376
+2.3%
0.00%0.0%
Q2 2019$2,084,000
-1.5%
100,076
+5.7%
0.00%0.0%
Q1 2019$2,116,000
-9.6%
94,676
-3.3%
0.00%
-25.0%
Q4 2018$2,341,000
-12.5%
97,876
-0.2%
0.00%0.0%
Q3 2018$2,674,000
+11.8%
98,027
+10.2%
0.00%0.0%
Q2 2018$2,391,000
-13.5%
88,927
+2.4%
0.00%0.0%
Q1 2018$2,764,000
+20.4%
86,827
+43.0%
0.00%
+33.3%
Q4 2017$2,296,000
+145.8%
60,703
+61.1%
0.00%
+200.0%
Q3 2017$934,000
+19.3%
37,678
-1.1%
0.00%0.0%
Q2 2017$783,000
+13.8%
38,078
+20.2%
0.00%0.0%
Q1 2017$688,000
+4.9%
31,678
-1.2%
0.00%0.0%
Q4 2016$656,000
+39.0%
32,078
+1.9%
0.00%0.0%
Q3 2016$472,000
+227.8%
31,478
+136.7%
0.00%
Q2 2016$144,000
-20.0%
13,3000.0%0.00%
Q1 2016$180,000
-31.8%
13,300
-7.0%
0.00%
-100.0%
Q4 2015$264,00014,3000.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 3,967,900$42,933,00029.35%
TLP GROUP LLC 2,833,285$30,656,00020.86%
Aisling Capital LLC 2,990,000$32,352,0007.64%
Vivo Capital, LLC 763,009$8,256,0002.26%
RA Capital Management 1,292,940$13,990,0001.94%
Foresite Capital Management III, LLC 235,020$2,543,0001.74%
Palo Alto Investors LP 325,599$3,523,0000.27%
Rock Springs Capital Management LP 293,000$3,170,0000.24%
EMERALD MUTUAL FUND ADVISERS TRUST 332,625$3,599,0000.20%
Virtus ETF Advisers LLC 19,501$211,0000.16%
View complete list of AIMMUNE THERAPEUTICS INC shareholders